Is CTSH a good stock to buy?
Cognizant Technology Solutions Corporation · end-of-day data as of Nov 13, 2026
- PT$68.38 +8.5%
- ConsensusBuy · 29
- P/E vs sector-60.9%
- FCF yield+8.4%
- Trendbullish
- MAs3 of 4
- Earnings in82d
- P/E11.5x
- RSI47
- Support-4.3%
- Resistance+1.6%
- Off 52w high-27.6%
- Volume0.4x
- Bollingerlower half
- News0.00
- P/E vs own-8.7%
- Sector→ -15.8%
- 52w range$37–$87
- ATR+3.9%
- Off ATH-32.6%
- Insiders-$184K
- MACD-0.54
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Cognizant a good stock to buy?
Cognizant is strong on 3 of the 5 questions about the business. The price is low: 11.5 times its earnings, below its 3-year median of 16.0 (Nov 13, 2026). pretickt does not say whether to buy or sell.
- Demand steady
- Advantage hard to copy
- Economics profitable
- Execution delivers
- Fragility sturdy
- Price below its usual
CTSH sales growth revenue growth
+3%a year, for the last 3 yearsCognizant's sales grew 3% a year for 3 years, to $21.11B in fiscal 2025.
CTSH analysts' forecast revenue estimates
+5%the sales they expect next fiscal year, on the lastAnalysts expect Cognizant's sales to grow 5% to $22.1B in fiscal 2026 (20 analysts).
CTSH competitors
pretickt analysis+5%its sales in 12 months, on a year before
Cognizant's sales grew 5% in the 12 months to Sep 30, 2026, faster than Leidos (+3%) and Fiserv (-2%), slower than CDW (+11%) and Broadridge (+7%).
CTSH sales by business revenue by segment
30%of its sales from HealthcareHealthcare brought Cognizant 30% of its sales in fiscal 2025; Financial Services 29%.
CTSH return on capital ROIC
pretickt analysis22%earned before tax on the money invested in itCognizant earned 22% before tax on the capital invested in it in the 12 months to Sep 30, 2026; Leidos 40%, Broadridge 23%, CDW 21% and Fiserv -5%.
CTSH margin on each sale gross margin
32%left after making the productCognizant kept 32% of each sale after making the product in the 12 months to Sep 30, 2026; its competitors' median is 26%.
CTSH margin after costs profit margin
16%of sales left after running the businessCognizant's operating margin was 16% in the 12 months to Sep 30, 2026, against 15% in fiscal 2022.
CTSH cash generated free cash flow
$2.36Bcash left after investing, last 12 monthsCognizant generated $2.36B of free cash flow in the 12 months to Sep 30, 2026, about as much as its reported profit.
CTSH earnings vs estimates
7 of 8quarters above the analysts' estimateCognizant beat the analysts' profit estimate in 7 of its last 8 quarters, the latest on Oct 29, 2026.
CTSH insider selling
-$5.91Msold, net, by its executives in 12 monthsCognizant's executives and directors sold a net $5.91M of shares in the 12 months to Nov 13, 2026 ($6.12M sold, $210K bought).
CTSH number of employees
+4%more people in a yearCognizant had 351,600 employees at the end of fiscal 2025, 4% more than a year before.
CTSH CEO pay
$21.53Mfor fiscal 2025, 73% of it in stock and optionsCognizant paid its CEO $21.53M for fiscal 2025, 73% of it in stock and options.
CTSH financial health Altman Z-score
5.4Altman Z-score, safe above 3Cognizant's Altman Z-score is 5.4 (Nov 13, 2026), above 3, where the safe zone starts.
CTSH quality checks Piotroski score
5 of 9checks passedCognizant passes 5 of the 9 Piotroski checks in the 12 months to Sep 30, 2026; it misses on long-term debt, the current ratio, gross margin and sales for its assets.
CTSH in past recessions
pretickt analysis-1%its sales in the worst oneCognizant's sales fell in 1 of the last 2 US recessions, by as much as 1% in fiscal 2020.
CTSH price vs profit P/E ratio
11.5×a year's earningsCognizant's P/E ratio is 11.5 (Nov 13, 2026), below its 3-year median of 16.0.
CTSH price vs competitors
pretickt analysis11.5×a year's earnings, against its competitorsInvestors pay 11.5 times Cognizant's earnings (Nov 13, 2026), less than for Broadridge (21.3), CDW (20.0) or Leidos (11.7).
CTSH analysts' target price target
+9%to their average targetAnalysts' average price target for Cognizant is $68.38, 9% above the Nov 13, 2026 close of $63.01.
CTSH growth priced in fair value
pretickt analysis0%a year, for ten years, to be worth the priceAt $63.01 a share, Cognizant's free cash flow only has to hold level for ten years to be worth the price (Nov 13, 2026).
What is Cognizant's P/E ratio?
Cognizant's P/E ratio is 11.5 (Nov 13, 2026), below its 3-year median of 16.0. Investors pay 11.5 times Cognizant's earnings (Nov 13, 2026), less than for Broadridge (21.3), CDW (20.0) or Leidos (11.7).
Who are Cognizant's biggest competitors?
pretickt compares Cognizant with Fiserv, Broadridge, CDW and Leidos. Cognizant's sales grew 5% in the 12 months to Sep 30, 2026, faster than Leidos (+3%) and Fiserv (-2%), slower than CDW (+11%) and Broadridge (+7%).
Is Cognizant profitable?
Cognizant's operating margin was 16% in the 12 months to Sep 30, 2026, against 15% in fiscal 2022. Cognizant generated $2.36B of free cash flow in the 12 months to Sep 30, 2026, about as much as its reported profit.
Are insiders selling Cognizant stock?
Cognizant's executives and directors sold a net $5.91M of shares in the 12 months to Nov 13, 2026 ($6.12M sold, $210K bought).
How does Cognizant make money?
Healthcare brought Cognizant 30% of its sales in fiscal 2025; Financial Services 29%.
How many employees does Cognizant have?
Cognizant had 351,600 employees at the end of fiscal 2025, 4% more than a year before.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.